Biotech's Finest Hour: A Discussion on Corporate Leadership and Equity

10:15 AM - 11:00 AM (EST), Tuesday, February 16, 2021
The past year has been a whirlwind for leaders, businesses, and the biotech industry. The COVID-19 pandemic, economic and political uncertainty, and a focus on social justice has changed society. Join us for an in-depth conversation with BIO’s President and CEO, Dr. Michelle McMurry-Heath and Nasdaq’s President and CEO, Adena T. Friedman on key initiatives in financial services and biotechnology that will shape the future including Nasdaq’s commitment to board diversity and the BIOEquality Agenda.
President and Chief Executive Officer
Nasdaq, Inc.
President and CEO
Biotechnology Innovation Organization